CHARTING A NEW COURSE IN THE TREATMENT AND
REHABILITATION OF POST COVID-19 COPD AND CHF PATIENTS…
USING ADVANCED THERAPEUTICS AND DIAGNOSTICS…
• In 2017 Phoenix Healthcare Network entered into an agreement to distribute the MyNicas Hemodynamic Monitoring System with NI-Medical in Israel.
• In 2020 MyNicas, located in California, took over national distribution for the product. Cardio NAV incorporates the MyNicas as part of its’ on-site Cardio-Pulmonary Rehabilitation Programs treating COPD and CHF patients and also sells MyNicas under a sales agreement.
CardioNav is a proactive program, grounded in education, technology and proven clinical outcomes. In only three minutes we are able to obtain hemodynamic, respiratory and fluids parameters. With CardioNav the care of cardiac patients in a Post-Acute setting can advance to a more sophisticated level by detecting and preventing heart failure episodes up to two weeks prior to the onset of symptoms.
CardioNav utilizes the advanced technology of MyNicas Hemodynamic NAVIGATOR as the primary technical component of the program. Our leading-edge technology delivers results that are accurate and consistent. Numerous clinical studies found a good correlation to Swan Ganz Cathetherization, some of which even suggest that MyNicas might be more accurate and may better respond to vasodilation therapy.
PHOENIX HEALTHCARE WEB-SITES ARE PROVIDED TO QUALIFIED
MEDICAL PROFESSIONALS FOR REFERENCE AND ARE NOT INTENDED
TO PROVIDE SPECIFIC MEDICAL ADVICE FOR PATIENTS
PATIENTS: SHOULD YOU HAVE ANY QUESTIONS REGARDING ANY PRODUCTS AND/OR SERVICES ON OUR WEB-SITES WE URGE YOU TO CONSULT WITH A QUALIFIED PHYSICIAN FOR DIAGNOSIS AND FOR ANSWERS TO YOUR SPECIFIC MEDICAL QUESTIONS